J A Kovacs1, H Masur. Show Affiliations » 1. Critical Care Medicine Department, National Institutes of Health, Bethesda, Maryland 20892.
Abstract
Entities: Disease
Mesh: See more » Acquired Immunodeficiency Syndrome/complicationsAnti-Bacterial Agents/administration & dosageAnti-Bacterial Agents/therapeutic useDapsone/administration & dosageDapsone/therapeutic useDrug Combinations/administration & dosageDrug Combinations/adverse effectsDrug Combinations/therapeutic useDrug Therapy, CombinationHumansPentamidine/administration & dosagePentamidine/therapeutic usePneumonia, Pneumocystis/drug therapyPneumonia, Pneumocystis/etiologyPneumonia, Pneumocystis/prevention & controlPyrimethamine/therapeutic useQuinazolines/therapeutic useRecurrenceSulfadiazine/therapeutic useSulfamethoxazole/administration & dosageSulfamethoxazole/adverse effectsSulfamethoxazole/therapeutic useTrimethoprim/administration & dosageTrimethoprim/adverse effectsTrimethoprim/therapeutic useTrimethoprim, Sulfamethoxazole Drug CombinationTrimetrexate
Substances: See more » Anti-Bacterial AgentsDrug CombinationsQuinazolinesSulfadiazinePentamidineTrimethoprim, Sulfamethoxazole Drug CombinationDapsoneTrimethoprimSulfamethoxazoleTrimetrexatePyrimethamine
Year: 1988 PMID: 2969023 DOI: 10.1093/infdis/158.1.254
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226